Podcasts about Colorectal Cancer Alliance

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NZA865. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 30, 2026.Catalysts for Redefined Care in Colorectal Cancer: Adapting Systemic Therapy Regimens Across Disease Settings In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported through independent medical education grants from Bristol Myers Squibb and GSK.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NZA865. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 30, 2026.Catalysts for Redefined Care in Colorectal Cancer: Adapting Systemic Therapy Regimens Across Disease Settings In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported through independent medical education grants from Bristol Myers Squibb and GSK.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NZA865. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 30, 2026.Catalysts for Redefined Care in Colorectal Cancer: Adapting Systemic Therapy Regimens Across Disease Settings In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported through independent medical education grants from Bristol Myers Squibb and GSK.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NZA865. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 30, 2026.Catalysts for Redefined Care in Colorectal Cancer: Adapting Systemic Therapy Regimens Across Disease Settings In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported through independent medical education grants from Bristol Myers Squibb and GSK.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NZA865. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 30, 2026.Catalysts for Redefined Care in Colorectal Cancer: Adapting Systemic Therapy Regimens Across Disease Settings In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported through independent medical education grants from Bristol Myers Squibb and GSK.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NZA865. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 30, 2026.Catalysts for Redefined Care in Colorectal Cancer: Adapting Systemic Therapy Regimens Across Disease Settings In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported through independent medical education grants from Bristol Myers Squibb and GSK.Disclosure information is available at the beginning of the video presentation.

What's it like when you are the only African American dancer in a world of all white dancers? Lisa continues our very special interview with Jennifer Jones, the first African American Rockette. Jennifer talks about growing up seeing Broadway shows with her parents. She told her high school guidance counselor that she wanted to go to college and major in dance. Her counselor told her that she wasn't ready for college yet, although at a very early age, she always dreamed of being on stage. She was so passionate and started at a local community college before moving to New York City, auditioning, and getting hired to be a Rockette. She talks about how spectacular Radio City Music Hall is. It literally took her breath away! She shares the excitement of the famous Christmas Spectacular show and how she poured her heart into each show. She was performing up to six shows a day. Jennifer discusses resilience, and what she had to break through to make her dreams come true. She noted that this year is the 100-year anniversary of the Rockettes and a big event will be planned to celebrate. She also talks about her challenges, and how important it is to believe in yourself. She discusses the importance of being resilient. When she turned 50, she went to her doctor to request a colonoscopy. The doctor told her she was young and had nothing to worry about as she was healthy and had no family members with colorectal cancer. Jennifer listened to her powerful intuition and got a colonoscopy anyway. The doctors determined that she had colorectal cancer, and she was told she had five years to live. She felt embarrassed by this diagnosis as she was always the “healthy one” in her family. She was physically fit and a vegetarian. She met with a specialist and had four rounds of chemotherapy. To the amazement of her doctors, the tests showed dramatic improvement. She explains how she decided to meditate more, let go of toxic relationships, drink green juices, and so much more. She knew she needed to change the way she ate and the way she thought. In 2019, she was deemed cancer-free! Jennifer talks about testing early for colorectal cancer, and especially in the African American community. If there's a history in your family, it's important to test even earlier. She shares how her symptoms started as pressure in her abdomen, so she began changing her diet and meeting with doctors. She talks about organizations who can offer early detection and additional support including Colorectal Cancer Alliance: https://colorectalcancer.org and Colon Cancer Foundation: https://coloncancerfoundation.org. Jennifer's groundbreaking memoir is titled “Becoming Spectacular: The Rhythm of Resilience from the First African American Rockette.” This is Part 2 of the interview. Info: rockettejenn.com.

Originally broadcast April 3, 2025 Roughly 85% of respondents to a survey cited by Michael Sapienza, CEO of the Colorectal Cancer Alliance, say they would rather do their taxes than get a colonoscopy. “We need to do a better job of talking to the public about the barriers,” Sapienza tells “Conversations on Health Care” hosts Mark Masselli and Margaret Flinter. Sapienza, whose mother died of the disease at age 58, says people may be less than excited to do the... Read More Read More The post ‘If Ryan Reynolds doesn't get you to do it…': Colorectal Cancer Alliance CEO talks screening appeared first on Healthy Communities Online.

Roughly 85% of respondents to a survey cited by Michael Sapienza, CEO of the Colorectal Cancer Alliance, say they would rather do their taxes than get a colonoscopy.“We need to do a better job of talking to the public about the barriers,” Sapienza tells "Conversations on Health Care" hosts Mark Masselli and Margaret Flinter.Sapienza, whose mother died of the disease at age 58, says people may be less than excited to do the preparation, or colon cleanout, necessary for a screening. Or that they don't want the hassle of taking time off from work. But he emphasized that 45 is the recommended age that people begin getting regular screenings for polyps that, at some point, could develop into cancer.“45 is the new 50," says Sapienza, whose alliance was instrumental in lowering the recommended screening age and, in 2022, recruited actors Ryan Reynolds and Rob McElhenney to have their colon screenings filmed. Learn more about your ad choices. Visit podcastchoices.com/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Roughly 85% of respondents to a survey cited by Michael Sapienza, CEO of the Colorectal Cancer Alliance, say they would rather do their taxes than get a colonoscopy. “We need to do a better job of talking to the public about the barriers,” Sapienza tells "Conversations on Health Care" hosts Mark Masselli and Margaret Flinter. Sapienza, whose mother died of the disease at age 58, says people may be less than excited to do the preparation, or colon cleanout, necessary for a screening. Or that they don't want the hassle of taking time off from work. But he emphasized that 45 is the recommended age that people begin getting regular screenings for polyps that, at some point, could develop into cancer. “45 is the new 50," says Sapienza, whose alliance was instrumental in lowering the recommended screening age and, in 2022, recruited actors Ryan Reynolds and Rob McElhenney to have their colon screenings filmed. Learn more about your ad choices. Visit podcastchoices.com/adchoices

A Survivor's Call to Action: Understanding Colorectal CancerThe discussion centers on the critical importance of colorectal cancer awareness, particularly during the month dedicated to its recognition. I emphasize the significance of early detection, underscoring that the survival rate markedly improves when the disease is identified at its localized stage. With colorectal cancer being the second leading cause of cancer-related mortality in the United States, it is paramount for individuals to engage in regular screenings, which the U.S. Preventive Services Task Force recommends starting at the age of 45. Moreover, I highlight the alarming increase in colorectal cancer incidence among adults under 50, which necessitates urgent attention and advocacy for improved healthcare access. The Colorectal Cancer Alliance plays a vital role in this endeavor, providing resources, education, and support to patients and their families while advocating for necessary policy changes.Takeaways: Colorectal Cancer Awareness Month is crucial for educating the public about this disease. Early detection significantly enhances survival rates, particularly when cancer is diagnosed at a localized stage. Regular screenings for colorectal cancer should commence at age 45, or earlier for those at higher risk. The Colorectal Cancer Alliance provides vital resources and support for patients and their families. Awareness and education efforts are essential in combating the rising incidence of colorectal cancer among younger adults. Participating in events and sharing information can greatly contribute to colorectal cancer advocacy and research funding. Links referenced in this episode:ratethispodcast.com/resessions

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/UCS865. CME/MOC/AAPA/IPCE credit will be available until February 24, 2026.The Personalized Paradigm in CRC Care: Translating Emerging Evidence to Guide Therapy Selection in Advanced Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Bristol Myers Squibb, Pfizer, and Takeda Pharmaceuticals U.S.A., Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/UCS865. CME/MOC/AAPA/IPCE credit will be available until February 24, 2026.The Personalized Paradigm in CRC Care: Translating Emerging Evidence to Guide Therapy Selection in Advanced Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Bristol Myers Squibb, Pfizer, and Takeda Pharmaceuticals U.S.A., Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/UCS865. CME/MOC/AAPA/IPCE credit will be available until February 24, 2026.The Personalized Paradigm in CRC Care: Translating Emerging Evidence to Guide Therapy Selection in Advanced Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Bristol Myers Squibb, Pfizer, and Takeda Pharmaceuticals U.S.A., Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/UCS865. CME/MOC/AAPA/IPCE credit will be available until February 24, 2026.The Personalized Paradigm in CRC Care: Translating Emerging Evidence to Guide Therapy Selection in Advanced Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Bristol Myers Squibb, Pfizer, and Takeda Pharmaceuticals U.S.A., Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/UCS865. CME/MOC/AAPA/IPCE credit will be available until February 24, 2026.The Personalized Paradigm in CRC Care: Translating Emerging Evidence to Guide Therapy Selection in Advanced Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Bristol Myers Squibb, Pfizer, and Takeda Pharmaceuticals U.S.A., Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/UCS865. CME/MOC/AAPA/IPCE credit will be available until February 24, 2026.The Personalized Paradigm in CRC Care: Translating Emerging Evidence to Guide Therapy Selection in Advanced Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Bristol Myers Squibb, Pfizer, and Takeda Pharmaceuticals U.S.A., Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/UCS865. CME/MOC/AAPA/IPCE credit will be available until February 24, 2026.The Personalized Paradigm in CRC Care: Translating Emerging Evidence to Guide Therapy Selection in Advanced Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Bristol Myers Squibb, Pfizer, and Takeda Pharmaceuticals U.S.A., Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/UCS865. CME/MOC/AAPA/IPCE credit will be available until February 24, 2026.The Personalized Paradigm in CRC Care: Translating Emerging Evidence to Guide Therapy Selection in Advanced Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Bristol Myers Squibb, Pfizer, and Takeda Pharmaceuticals U.S.A., Inc.Disclosure information is available at the beginning of the video presentation.

How can small businesses rebuild after a crisis like the recent LA fires? The Small Business Administration (SBA) plays a crucial role in recovery; offering financial assistance, business counseling, and disaster relief. Many independent contractors and home-based businesses don't realize they qualify for SBA loans, but resources are available for a wide range of business types. Julie Clowes, Director of SBA's Los Angeles District Office, joins us to discuss how the SBA provides critical support, especially in times of rebuilding after disaster. From financial assistance to business counseling, the SBA helps entrepreneurs access vital aid. Their local assistance tool on SBA.gov connects businesses with nearby advisors and recovery services. In response to the fires, the SBA is actively providing financial relief and guidance to help businesses, homeowners, and communities rebuild—while also emphasizing policy changes and mitigation efforts to strengthen future resilience.   You'll learn:  How small businesses can access resources like district offices and business centers. What kind of assistance the SBA has to offer in response to the recent LA fires. Who is encouraged to apply for SBA loans and aid. Learn critical strategies for small businesses to prepare for and recover from future disasters. Where individuals can locate resources based on their zip code for small business assistance.   About the Guest: Julie Clowes is the Director of SBA's Los Angeles District Office where she oversees delivery of SBA's programs and services within Los Angeles, Ventura and Santa Barbara counties.  Prior to joining the LADO Julie held numerous positions within SBA including Acting Deputy Associate Administrator -Office of Entrepreneurial Development, Director of the San Francisco District Office, Deputy District Director of the Washington Metropolitan Area District Office, Chief Marketing & Outreach attorney in the Office of General Counsel and Public Affairs Specialist with the Michigan District Office. Julie also volunteers her time for colorectal cancer advocacy efforts and was a Board member of the Colorectal Cancer Alliance.   Engage with us: LinkedIn, Instagram & Facebook: @PasadenaCityCollegeEWD Join our newsletter for more on this topic: ewdpulse.com Visit: PCC EWD website   More from Julie Clowes & U.S. Small Business Administration   Website: https://www.sba.gov/ LinkedIn: @julie-clowes & @us-small-business-administration Facebook & X (Twitter): @sba.gov   Partner with us! Contact our host Salvatrice Cummo directly: scummo@pasadena.edu Want to be a guest on the show? Click HERE to inquire about booking    Find the transcript of this episode here   Please rate us and leave us your thoughts and comments on Apple Podcasts; we'd love to hear from you!  

- Intro of Buck and Lyfe Brew- Cy Young Announcements and thoughts - Most Impactful December trades in Phillies history - Juan Soto - Front Office Announcements- Tailgating versus Xfinity Live expansion - Colorectal Cancer Alliance donation - Trade value - Minor League segment - Trivia Question and Odumbass - Outside the box Offseason move ideas

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/JXZ865. CME/MOC/AAPA/IPCE credit will be available until November 7, 2025.Accelerating Personalized Care in CRC: The Prominent Role of Predictive Biomarkers and Immunotherapy Platforms in Early and Advanced Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/JXZ865. CME/MOC/AAPA/IPCE credit will be available until November 7, 2025.Accelerating Personalized Care in CRC: The Prominent Role of Predictive Biomarkers and Immunotherapy Platforms in Early and Advanced Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/JXZ865. CME/MOC/AAPA/IPCE credit will be available until November 7, 2025.Accelerating Personalized Care in CRC: The Prominent Role of Predictive Biomarkers and Immunotherapy Platforms in Early and Advanced Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/JXZ865. CME/MOC/AAPA/IPCE credit will be available until November 7, 2025.Accelerating Personalized Care in CRC: The Prominent Role of Predictive Biomarkers and Immunotherapy Platforms in Early and Advanced Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/JXZ865. CME/MOC/AAPA/IPCE credit will be available until November 7, 2025.Accelerating Personalized Care in CRC: The Prominent Role of Predictive Biomarkers and Immunotherapy Platforms in Early and Advanced Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/JXZ865. CME/MOC/AAPA/IPCE credit will be available until November 7, 2025.Accelerating Personalized Care in CRC: The Prominent Role of Predictive Biomarkers and Immunotherapy Platforms in Early and Advanced Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/JXZ865. CME/MOC/AAPA/IPCE credit will be available until November 7, 2025.Accelerating Personalized Care in CRC: The Prominent Role of Predictive Biomarkers and Immunotherapy Platforms in Early and Advanced Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/JXZ865. CME/MOC/AAPA/IPCE credit will be available until November 7, 2025.Accelerating Personalized Care in CRC: The Prominent Role of Predictive Biomarkers and Immunotherapy Platforms in Early and Advanced Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation.

In this episode, we dive into all things summer! We catch up on everyone's travel adventures and home renovations, including the exciting addition of a brand new guest room and Holland's colorful "rainbow room." Plus, in a surprising twist, we learn that Mollie has an impressive talent—she can identify 40 different New England birds just by their calls! It's been a great summer for us, and we hope it has been for you too.As always, don't forget to like, subscribe, follow, and tell a friend to tell a friend about the podcast. We appreciate you all!Hiltons renovations on IGRainbow RoomGuest RoomBathroomDonate to The Bottoms Up® Invitational, presented by Craig Melvin and Lindsay Czarniak, benefits the Colorectal Cancer Alliance. The event honors Craig's brother, Lawrence Meadows.

Champions of the peer-to-peer industry understand that P2P events go far beyond just fundraising, raising awareness or building community. For those directly affected by our causes, these events can provide a powerful outlet for emotional healing—a meaningful way to take action, mourn, celebrate and feel less isolated in their struggles.However, this critical component can often be overshadowed by broader fundraising and marketing strategies. In our efforts to design events that attract the widest possible audience, we can lose sight of creating experiences that truly center those most directly impacted.In this episode, Marcie Maxwell of P2PPF is joined by Chelsea Edwards, Senior Director of Peer-to-Peer Giving at the Colorectal Cancer Alliance, to discuss the recent transformation of the organization's flagship event from the Undy Run to the Walk To End Colon Cancer. Together, they explore the motivations behind this shift and the strategic decision to redesign the event to better serve those diagnosed with colorectal cancer and their loved ones, rather than just the general public. Chelsea delves into how their new signature experience, “A Moment of Unsilence,” was developed and the profound impact it has had on the community.This episode also covers:Emotional healing as a cornerstone of P2P eventsSecuring buy-in from leadership and local communities for changeThe non-revenue benefits of P2P communitiesMentioned LinksColorectal Cancer AllianceStay Connected on LinkedInConnect with ChelseaConnect with MarcieConnect with the Peer-to-Peer Professional Forum (00:00) - Welcome to The P2P Soap Box (01:41) - Introducing Chelsea Edwards (06:36) - The Undie Run Transformation (14:06) - The Moment of Unsilence (22:24) - Training For Impact (30:54) - Get Involved

Today's guest is Tara Lehnertz, a colorectal cancer survivor. Diagnosed 3 days after her honeymoon, her journey eventually led her to the support of the Colorectal Cancer Alliance, where she is now an advocate and a "buddy" for others going through colorectal cancer. You can find the buddy service here:https://colorectalcancer.org/resources-support/community-support/buddy-program/buddy-program-request-formWe talk about community, self care, both mental and physical, the importance of advocating for yourself, not sweating the small stuff, and so much more!You can connect with Tara on LinkedIn: https://www.linkedin.com/in/taralehnertz/Or Facebook:https://www.facebook.com/tara.kelsostutevillePlease let me know any takeaways you've gotten from this episode or any other. I want to hear from you!! You can reach me on Instagram at https://www.instagram.com/melissagrosboll/, email me at drmelissagrosboll@gmail.com, or text me at 720-201-4292.

In this episode of the Target: Cancer Podcast, Dr. Sanjay Juneja dives deep into the latest developments in colorectal cancer with Michael Sapienza, CEO of the Colorectal Cancer Alliance. Michael shares his personal journey from professional musician to leading cancer advocate, inspired by his mother's battle with the disease. Discover the urgent need for innovative treatments and how advancements in AI and data sharing can revolutionize colorectal cancer care. Learn about cutting-edge screening methods, the critical importance of early detection, and the ongoing efforts to improve funding and research for colorectal cancer prevention.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/JPD865. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 30, 2025.Precision Tactics in HER2-Positive GI Malignancies: Capitalizing on HER2-Targeted Regimens to Improve Outcomes for Gastric/GEJ Cancers, CRC, and BTC In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, the Cholangiocarcinoma Foundation, and the Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AstraZeneca and Daiichi Sankyo, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/JPD865. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 30, 2025.Precision Tactics in HER2-Positive GI Malignancies: Capitalizing on HER2-Targeted Regimens to Improve Outcomes for Gastric/GEJ Cancers, CRC, and BTC In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, the Cholangiocarcinoma Foundation, and the Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AstraZeneca and Daiichi Sankyo, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/JPD865. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 30, 2025.Precision Tactics in HER2-Positive GI Malignancies: Capitalizing on HER2-Targeted Regimens to Improve Outcomes for Gastric/GEJ Cancers, CRC, and BTC In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, the Cholangiocarcinoma Foundation, and the Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AstraZeneca and Daiichi Sankyo, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/JPD865. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 30, 2025.Precision Tactics in HER2-Positive GI Malignancies: Capitalizing on HER2-Targeted Regimens to Improve Outcomes for Gastric/GEJ Cancers, CRC, and BTC In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, the Cholangiocarcinoma Foundation, and the Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AstraZeneca and Daiichi Sankyo, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/JPD865. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 30, 2025.Precision Tactics in HER2-Positive GI Malignancies: Capitalizing on HER2-Targeted Regimens to Improve Outcomes for Gastric/GEJ Cancers, CRC, and BTC In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, the Cholangiocarcinoma Foundation, and the Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AstraZeneca and Daiichi Sankyo, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/JPD865. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 30, 2025.Precision Tactics in HER2-Positive GI Malignancies: Capitalizing on HER2-Targeted Regimens to Improve Outcomes for Gastric/GEJ Cancers, CRC, and BTC In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, the Cholangiocarcinoma Foundation, and the Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AstraZeneca and Daiichi Sankyo, Inc.Disclosure information is available at the beginning of the video presentation.

Why is there an increase in young people dying from Colorectal Cancer? Why are young people dying at a greater rate than anyone else? Are people under 50 too young to get colorectal cancer? In this episode of "Everyday Conversations on Race," Simma Lieberman, The Inclusionist, is joined by Lisa Hall, Senior Director of Prevention and Screening at the Colorectal Cancer Alliance, and Michael Sapienza, CEO of the Colorectal Cancer Alliance. They tell us why so many people are being diagnosed too late, and why more non-white people are dying compared to white people. Michael shares his personal story of his mother's death and the impact it had on him when he was young.   Lisa talks about health disparities and how important her work with the Colorectal Cancer Alliance is to her as a Black woman. Listen to learn more about this critical health disparity affecting people of color and. the racial disparities in screening, diagnosis and deaths from colorectal cancer. At the end of this episode you'll know what you can do for yourself, how you can help your community and how you can support your friends who may be at risk, no matter who they are.   Click here to DONATE and support our podcast   Key Moments: [00:01:08] Racial disparity in colorectal cancer. [00:06:43] Early detection in minority populations. [00:10:37] Expanding colorectal cancer screening age. [00:15:19] Understanding average risk for screenings. [00:18:35] Screening disparities and awareness. [00:21:19] Advocating for your health. [00:27:13] Importance of early screening. [00:29:52] Resources for colorectal cancer.   Guests Bio Michael Sapienza, Chief Executive Officer of the Colorectal Cancer Alliance, lost his mother to the disease in May 2009. He turned his profound grief into action, inspiring and challenging the colorectal cancer community, family, friends, and professional associates to follow his lead and dedicate themselves to ending colorectal cancer within our lifetime—now the mission of the Colorectal Cancer Alliance. Michael served as President and Founder of The Chris4Life Colon Cancer Foundation from 2010-2015. He was an integral member of the team that led the effort to merge the Chris4Life Colon Cancer Foundation and the Colon Cancer Alliance, creating the nation's largest colon cancer specific nonprofit. In 2017, the Colon Cancer Alliance changed its name to Colorectal Cancer Alliance, embracing the entire colorectal cancer community. Lisa Hall is a healthcare leader with extensive, proven expertise in strategic client management and development. During her career, she has applied her proven experience in cultivating and managing successful, complex relationships to drive forward both the client and organizations business agendas; She has done so while demonstrating results for influencing business outcomes achieving solid, consistent, market share and profit gains. Lisa's business approach exemplifies her skills in consultative selling and building relationships with clients and prospects that ensures long-term, client solutions and business growth.   Click here to DONATE and support our podcast   Simma Lieberman, The Inclusionist helps leaders create inclusive cultures. She is a consultant, speaker, and facilitator. Simma is the creator and host of the podcast, “Everyday Conversations on Race for Everyday People.” Contact Simma@SimmaLieberman.com to get more information, book her for your next DEIB  event, help you become a more inclusive leader, or facilitate dialogues across differences. Go to www.simmalieberman.com and www.raceconvo.com for more information Simma is a member of and inspired by the global organization IAC (Inclusion Allies Coalition)    Connect with me: Instagram Facebook YouTube Twitter LinkedIn Tiktok Website    Previous Episodes Navigating the End of Racial Disparities in Healthcare Culture Connects Us Black Modern Elder Academy: Creating a Space for Authenticity and Diverse Experiences Loved this episode?  Leave us a review and rating

PART 2 of our coverage of young-onset colorectal cancer! This week our guest is an Oncology expert, here to give us in-depth information about colorectal cancer, with actionable items on how we can protect ourselves. Colorectal cancer in younger folks (under 50 years old) is unfortunately on the rise. According to the Colorectal Cancer Alliance, in the US, about 10% of colorectal cancer cases are diagnosed in people under 50.  Did you know that in 2021, the USPSTF (the federal task force that creates and implements screening guidelines in the US) changed their colorectal cancer screening guidelines? Instead of average-risk folks getting their first screening colonoscopy at 50 (the previous standard), the recommendation is now to start at 45! Your Doctor Friends are happy to present a physician expert in colorectal cancer to provide even more helpful information about why this disease may be targeting younger people, and what we can do as individuals to protect ourselves and those we care about :) Welcome, Meena Sadaps, MD! Dr. Sadaps is a board certified oncologist and assistant professor with Your Doctor Friends at Rush, and practices at the RUSH MD Anderson Cancer Center. She attended Sidney Kimmel Medical College at Thomas Jefferson University before completing residency and fellowship at Cleveland Clinic. HEADS UP! The Colorectal Cancer Alliance Blue Hope Bash annual fundraising event in Chicago is Friday, May 3rd, 2024, at Galleria Marchetti (where Jeremy got married!) and Your Doctor Friends plan to attend! If you can't attend the Blue Hope Bash, PLEASE CONSIDER DONATING to the Colorectal Cancer Alliance! Resources for this episode include: A 2021 review article from the World Journal of Gastrointestinal Oncology regarding young-onset colorectal cancer. The National Cancer Institute's website re: warning signs of young-onset colorectal cancer. A CNN article about the rise of young-onset colorectal cancer. Thanks for tuning in, folks! Please sign up for our "PULSE CHECK" monthly newsletter! Signup is easy, right on our website page, and we PROMISE we will not spam you! We just want to send you cool articles, videos and thoughts :) For more episodes, limited edition merch, or to become a Friend of Your Doctor Friends (and more), follow this link!   Find us at: Website: yourdoctorfriendspodcast.com  Email: yourdoctorfriendspodcast@gmail.com  Connect with us: @your_doctor_friends (IG) Send/DM us a voice memo/question and we might play it on the show! @yourdoctorfriendspodcast1013 (YouTube) @JeremyAllandMD (IG, FB, Twitter) @JuliaBrueneMD (IG) @HealthPodNet (IG)

Colorectal cancer in younger folks (under 50 years old) is unfortunately on the rise. According to the Colorectal Cancer Alliance, in the US, about 10% of colorectal cancer cases are diagnosed in people under 50.  Those numbers are rising about 1-2% percent each year, and researchers are still finding out why.  Young adults are the only population group experiencing an increase in colorectal cancer Colorectal cancer is currently the deadliest cancer among young men and the second deadliest among young women. In August 2020, the world lost amazing actor, Black Panther himself, Chadwick Boseman, to colorectal cancer at the age of 43. Did you know that in 2021, the USPSTF (the federal task force that creates and implements screening guidelines in the US) changed their colorectal cancer screening guidelines? Instead of average-risk folks getting their first screening colonoscopy at 50 (the previous standard), the recommendation is now to start at 45! Sharing personal experiences, and highlighting the stories of people touched by colorectal cancer is POWERFUL, and the ripple effects flow far. Your Doctor Friends are SO HONORED to highlight two wonderful individuals on this episode- Ashley Bowman, MHA and Dawn Schneider, PhD, MBA. Ashley and Dawn have quite a bit in common- they are both advocate volunteers at the Colorectal Cancer Alliance, members of the Never Too Young Taskforce Advisory Board, and unfortunately both lost sisters to young-onset colorectal cancer. Ashley and Dawn share their amazing, heartbreaking, and inspiring personal stories in this episode. We are so grateful! We will follow up next week with a physician expert in colorectal cancer to provide even more helpful information about why this disease may be targeting younger people, and what we can do as individuals to protect ourselves and those we care about :) HEADS UP! The Blue Hope Bash annual fundraising event in Chicago is Friday, May 3rd, 2024, at Galleria Marchetti (where Jeremy got married!) and Your Doctor Friends plan to attend! (Julie is already shopping for a fancy blue outfit :) COME JOIN US! Opportunities to register for the event CLOSE ON TUESDAY 4/23/24 (the day THIS EPISODE DROPS)! If you can't attend the Blue Hope Bash, PLEASE CONSIDER DONATING to the Colorectal Cancer Alliance! Resources for this episode include: A 2021 review article from the World Journal of Gastrointestinal Oncology regarding young-onset colorectal cancer. The National Cancer Institute's website re: warning signs of young-onset colorectal cancer. A CNN article about the rise of young-onset colorectal cancer. A CC Alliance article highlighting our guest, Ashley Bowman! A CC Alliance article highlighting our guest, Dawn Schneider! Thanks for tuning in, folks! Please sign up for our "PULSE CHECK" monthly newsletter! Signup is easy, right on our website page, and we PROMISE we will not spam you! We just want to send you cool articles, videos and thoughts :) For more episodes, limited edition merch, or to become a Friend of Your Doctor Friends (and more), follow this link!   Find us at: Website: yourdoctorfriendspodcast.com  Email: yourdoctorfriendspodcast@gmail.com  Connect with us: @your_doctor_friends (IG) Send/DM us a voice memo/question and we might play it on the show! @yourdoctorfriendspodcast1013 (YouTube) @JeremyAllandMD (IG, FB, Twitter) @JuliaBrueneMD (IG) @HealthPodNet (IG)

Highlights this week. Interviews may be abbreviated. For the date and hour podcast to hear more, see the note 0:00 Dr JoAnn di Filippo--trying to understand the Mosaic deal

Jasmine Mejia with the Colorectal Cancer Alliance speaking on Colorectal Cancer Awareness Month. An online tool to help give you guidance on screening, and other resources are available at quiz.getscreened.org Udall Park is now a homeless encampment. Got Plissken?

If you think Facebook doesn't work to acquire donors anymore, this case study with Chelsea Edwards from the Colorectal Cancer Alliance will prove you otherwise.For the past three years as the Senior Director of Peer-to-Peer Giving, Chelsea has been instrumental in amplifying their fundraising campaigns, like "Lead From Behind", which harnessed celebrity influencers like Ryan Reynolds. Partnering with GoodUnited on their messaging and Facebook fundraising efforts last year resulted in 440 people launching a campaign around “Blue Day'' and $3,705 raised, with $0 in ad spend! Chelsea breaks down the details of their strategy, including the messaging and segmenting they used to engage donors and the analytics they paid attention to. Interestingly, Facebook Messenger drove higher click-through rates as compared to email. We also explore the art of listening to your donors, using their stories to refine your strategies, ensuring that every click contributes to a narrative of hope and support.March is Colon Cancer Awareness Month. Learn more about how to support the cause.Resources & LinksLearn more about the Colorectal Cancer Alliance, including the upcoming ScopeItOut event in Washington DC. You can connect with Chelsea at cedwards@ccalliance.org or on LinkedIn. Want to make Missions to Movements even better? Take a screenshot of this episode and share it on Instagram. Be sure to tag @positivequation so I can connect with you. March 2024Join me on Thursday, March 14th at 10a PT / 1p ET for a FREE virtual event to learn how to supercharge your social fundraising and learn next-level tactics to deliver the right donors. Register here to join live or to get the replay.Are you ready to grow your email list with social ads in just seven days? Join the next round of my Grow Your List Ads Challenge where we'll create your lead magnet and ad copy and make sure that we're setting up your ads for success. Limited spots are left and we start the week of March 11th! Click here to register.Let's Connect! Send a DM on Instagram or LinkedIn and let us know what you think of the show! Head to YouTube for helpful digital marketing how-to videos and podcast teasers Want to book Dana as a speaker for your event? Click here!

This episode is a 360it revisiting the topics put on the table during Episode 88 : Biosimilars - Interchangeability & Switching 2023   Join us in this breakout 360it from Episode 88 Biosimilars : Interchangeability & Switching 2023 as we dissect the Inflation Reduction Act (IRA) and its potential fallout on patient access to diverse treatment plans. Tracing the historical trajectory of the IRA, we uncover its role in price negotiations and the concerning shift in investments away from critical drugs tailored for specific diseases. This reallocation poses a tangible threat to the availability and diversity of treatments, including for those living with AiArthritis diseases. As we dive into the landscape of healthcare policy, the discussion emphasizes the pressing need for IRA improvements to consider the long term well-being of patients. Without these crucial enhancements, we will have a future with not only fewer innovative treatments but potentially less treatment options available.    Join us in fighting for improvements to the IRA and patient involvement in treatment access.   Episode Highlights :  The history of Medicare Part D and its positive impact on healthcare What is the Inflation Reduction Act Why the IRA price negotiations are important to understand and how it will affect your treatment access  How healthcare R&D will be negatively impacted by the IRA price negotiations  Consequences to Patients of Drug Price-Setting Policies for patients How can patients get involved in the IRA price negotiations  How the IRA will disincentivize small molecule drugs and indications for treatment plans    Resources Mentioned In This Episode: AiArthritis Biosimilars Hotline: https://www.aiarthritis.org/biosimilars  EMA - What Is A Biosimilar : https://www.ema.europa.eu/en/human-regulatory/overview/biosimilar-medicines-overview ASBM Statement on CMS drugs list announcement - https://safebiologics.org/medicare-price-negotiations-will-jeopardize-patient-access-to-new-medicines-result-in-worse-health-outcomes/ ASBM webinar on IRA - https://safebiologics.org/july-26-webinar-on-ira-medicare-price-negotiations/ An educational microsite for patients to learn more and read news articles -  www.IRAPatientInfo.org    Meet Our Co-Hosts & Guests:  Tiffany is the CEO at International Foundation for AiArthritis and uses her professional expertise in mind-mapping and problem solving to help others, like her, who live with AiArthritis diseases work in unison to identify and solve unresolved community issues. Connect with Tiffany: Facebook: @tiffanyAiArthritis Twitter: @TiffWRobertson LinkedIn: @TiffanyWestrichRobertson   Andrew Spiegel has nearly two decades of experience in the patient advocacy arena. Spiegel co-founded the Colorectal Cancer Alliance and was longtime board member of the Alliance became CEO in January of 2008 and ran the CCA for nearly 5 years, before undertaking his next venture, the Global Colon Cancer Association (GCCA).In addition to his work in the colon cancer community, Spiegel is an active advocate for health care policies both in the US and now worldwide. He is a co-founder and currently serves on the steering committee of the Alliance for Safe Biologic Medicines (ASBM). He is on the Board of Directors, and in December 2014 was elected to Chair, of the Digestive Disease National Coalition (DDNC),a founding member of the Coalition to Increase Clinical Trial Participation and in May of 2016 he began a three year term as a member of the Board of Directors of the International Alliance of Patient Organizations (IAPO) where he chaired the fundraising committee. Spiegel has won multiple awards for his work in patient advocacy.   Michael Reilly, Executive Director of Alliance for Safe Biologic Medicines, has served as the executive director of ASBM since its inception in 2010. He has more than a decade of experience in the federal government developing and implementing healthcare policy. Mr. Reilly served as the associate deputy secretary at the U.S. Department of Health and Human Services (HHS) from 2005-2008 responsible for policy development and implementation, as well as regulatory oversight for issues involving CMS and the FDA. In addition to serving as the associate deputy secretary, Mr. Reilly served as a senior advisor to the assistant secretary for public affairs and the assistant secretary for planning and evaluation at HHS from 2002-2005. Mr. Reilly has been quoted in a series of FDA publications and co-authored many articles on biosimilars for the Generics and Biosimilars Initiative Journal. He has also presented to health regulators worldwide, including the Australian TGA, Health Canada and the World Health Organization (WHO).   Charles M Clapton. Mr Clapton has nearly two decades of Capitol Hill experience, Notably, he served as health policy director for the Senate Committee on Health, Education, Labor, and Pensions, aiding the passage of the FDA Safety and Innovation Act (2012). He also played a pivotal role as a lead Republican staffer during the Affordable Care Act's congressional deliberations. He also impacted the House Ways & Means and Energy & Commerce Committees by shaping Medicare Part D prescription drug benefits, revise drug payment methods for Medicare Part B, and Medicaid changes in the Deficit Reduction Act of 2005.   Thomas Barker represents healthcare providers and payers before the Centers for Medicare & Medicaid Services (CMS) and other components of the Department of Health and Human Services (HHS), Congress, and the Department of Labor. Tom is a former commissioner of the Medicaid and CHIP Payment and Access Commission (MACPAC), an advisory body that provides policy advice to Congress and the states on the Medicaid and CHIP programs. He is one of the authors of the firm's Medicaid & the Law blog, www.medicaidandthelaw.com, which highlights and explains current legal and policy issues in the Medicaid program. Donate to Support the Show: https://www.aiarthritis.org/donate  Sign up for our Monthly AiArthritis Voices 360 Talk Show newsletter! HERE AiArthritis Voices 360 is produced by the International Foundation for Autoimmune and Autoinflammatory Arthritis. Visit us on the web at www.aiarthritis.org/talkshow. Find us on Twitter, Instagram, TikTok, or Facebook (@IFAiArthritis) or email us (podcast@aiarthritis.org).  Be sure to check out our top-rated show on Feedspot!

Can a positive attitude help people thrive after cancer? Listen and learn from Ronald McCoy who is thriving after stage-4 colon cancer. Get more information about colon cancer: https://www.mayoclinic.org/diseases-conditions/colon-cancer/symptoms-causes/syc-20353669 Help people with colon cancer through the Colorectal Cancer Alliance: https://www.ccalliance.org/ --- Send in a voice message: https://podcasters.spotify.com/pod/show/cherie-hardy/message

On Monday, NY/LA-based saxophonist James Casey, a previous guest on our show, passed away at the age of 40 after battling cancer. He was a longtime member of the Trey Anastasio Band and has played with The Roots, Anderson .Paak, Carly Rae Jepsen, Jon Batiste, Talib Kweli, and many more artists. Today, we bring you a conversation with Angele Russell, senior director of partnerships & health equity at the Colorectal Cancer Alliance, which has worked with Casey on cancer advocacy. Plus, hear excerpts of Casey's conversation and performances from his November 2022 appearance on All Of It. This segment is guest hosted by Brigid Bergin.

This episode is a Step 5 - revisit to the table - as outlined in our 6 Step Patient-Led Problem Solving Process. What do patients need to know about the upcoming changes to biosimilars and interchangeability in 2023?    In this episode, Tiffany is joined by esteemed guest experts Michael Reilly, Dr. Ralph McKibbin and Andrew Spiegel to explore the crucial distinctions between interchangeability, automatic substitution, and non-medical switching. Gain valuable insights into how these differences impact patients not only in the USA but also on a global scale.   In addition, our guests discuss the latest proposed bills in the US regarding biosimilar interchangeability, offering expert perspectives on the legislative developments and their implications for patients and healthcare providers alike.   Join us on this episode as we explore the latest updates in biosimilar interchangeability and share ways to raise your voice against non-medical switching without physician involvement.     Episode Highlights :  What is the difference between Interchangeability, Automatic Substitution, and Non-Medical Switching? Latest proposed legislation regarding biosimilars interchangeability The importance of physician involvement in biosimilars interchangeability What is the chance of original biologic failure if you fail the biosimilar? (and other patient submitted questions) Updates on biosimilars advancements in the US and around the world  What are Automatic Substitution Laws? How to become involved in the fight against the new legislation proposed to remove “interchangeability” protections in switching    Resources Mentioned In This Episode: AiArthritis Biosimilars Hotline: https://www.aiarthritis.org/biosimilars  EMA - What Is A Biosimilar : https://www.ema.europa.eu/en/human-regulatory/overview/biosimilar-medicines-overview Meet Our Co-Hosts & Guests:  Tiffany is the CEO at International Foundation for AiArthritis and uses her professional expertise in mind-mapping and problem solving to help others, like her, who live with AiArthritis diseases work in unison to identify and solve unresolved community issues.   Connect with Tiffany: Facebook: @tiffanyAiArthritis Twitter: @TiffWRobertson LinkedIn: @TiffanyWestrichRobertson   Ralph McKibbin, MD, FACP, FACG, AGAF  is the Chairman of Alliance for Safe Biologic Medicines. Dr. McKibbin is a practicing gastroenterologist at Blair Gastroenterology Associates in Altoona, PA. He is past president of both the Pennsylvania Society of Gastroenterology and of the Digestive Disease National Coalition (DDNC). He sits on the Member Advisory Panel of the Pennsylvania Medical Society; and is a member of the Pennsylvania State Cancer Control Consortium. Dr. McKibbin has written extensively on the issues of non-medical switching and insurance industry utilization management techniques including step therapy and copay accumulator adjustments.   Andrew Spiegel has nearly two decades of experience in the patient advocacy arena. Spiegel co-founded the Colorectal Cancer Alliance and was longtime board member of the Alliance became CEO in January of 2008 and ran the CCA for nearly 5 years, before undertaking his next venture, the Global Colon Cancer Association (GCCA).In addition to his work in the colon cancer community, Spiegel is an active advocate for health care policies both in the US and now worldwide. He is a co-founder and currently serves on the steering committee of the Alliance for Safe Biologic Medicines (ASBM). He is on the Board of Directors, and in December 2014 was elected to Chair, of the Digestive Disease National Coalition (DDNC),a founding member of the Coalition to Increase Clinical Trial Participation and in May of 2016 he began a three year term as a member of the Board of Directors of the International Alliance of Patient Organizations (IAPO) where he chaired the fundraising committee. Spiegel has won multiple awards for his work in patient advocacy.   Michael Reilly, Executive Director of Alliance for Safe Biologic Medicines, has served as the executive director of ASBM since its inception in 2010. He has more than a decade of experience in the federal government developing and implementing healthcare policy. Mr. Reilly served as the associate deputy secretary at the U.S. Department of Health and Human Services (HHS) from 2005-2008 responsible for policy development and implementation, as well as regulatory oversight for issues involving CMS and the FDA. In addition to serving as the associate deputy secretary, Mr. Reilly served as a senior advisor to the assistant secretary for public affairs and the assistant secretary for planning and evaluation at HHS from 2002-2005. Mr. Reilly has been quoted in a series of FDA publications and co-authored many articles on biosimilars for the Generics and Biosimilars Initiative Journal. He has also presented to health regulators worldwide, including the Australian TGA, Health Canada and the World Health Organization (WHO).   Donate to Support the Show: https://www.aiarthritis.org/donate  Sign up for our Monthly AiArthritis Voices 360 Talk Show newsletter! HERE AiArthritis Voices 360 is produced by the International Foundation for Autoimmune and Autoinflammatory Arthritis. Visit us on the web at www.aiarthritis.org/talkshow. Find us on Twitter, Instagram, TikTok, or Facebook (@IFAiArthritis) or email us (podcast@aiarthritis.org).  Be sure to check out our top-rated show on Feedspot!

Hello friends and welcome back to our podcast, The Patients Speak, and happy New Year 2023. If you just started listening to our show over the first few episodes, you know we've heard many great stories and examples from leaders on how to listen better. Specifically, we've heard from patient advocates on the ways they promote the patient voice and how they share a commitment to helping us all elevate that voice to a whole new level.To start the new year, we wanted to share highlights of five patient advocacy guests to give you an idea of how they saw ways to accelerate the patient journey. We'll talk to Wendy Bjork, The Empress of MS. Michael Sapienza, the CEO of the Colorectal Cancer Alliance. Pam Cusick, Senior Vice President of Rare Patient Voice. Andrea Wilson Woods, founder and president of Blue Faery for Liver Cancer. Alicia Lawrence of NORD, the National Organization for Rare Diseases.We hope you enjoy this summary of interviews with patient advocates. Thanks to guests like these, we've enjoyed a solid start to our podcast. Already, we've had more than 5000 downloads and we've ranked in the top 0.5% of all podcasts. We've received over 700 five-star reviews on iTunes. Subscribe now, and if you'd like to leave us a comment or review or even a suggestion for a future guest, we'd certainly appreciate that.Thanks again to our sponsor, 83bar. If you'd like to know more about 83bar and the work they're doing in patient recruitment, patient education, and patient empowerment to create better patient outcomes, visit their website at 83bar.com.And certainly, come back again for our next episode. We'll continue our conversations with patient advocates like these, along with healthcare executives, clinical researchers, and medical providers -- all to give us insight into what we need to hear when the patients speak.